Biohaven Ltd. (BHVN)

[Name] Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	238.03	229.96	99.13	248.4	204.88	76.06
Short-Term Investments	29.83	89.18	386.86	133.42	260.46	-
Cash & Short-Term Investments	267.87	319.14	485.99	381.82	465.34	76.06
Cash Growth	-33.86%	-34.33%	27.28%	-17.95%	511.83%	-7.82%
Other Receivables	-	-	-	13.25	48.89	9.91
Receivables	-	-	-	13.25	48.89	9.91
Prepaid Expenses	27.04	47.02	49.38	35.24	20.95	6.73
Restricted Cash	0.1	0.53	0.28	1.32	0.12	0.25
Other Current Assets	1.55	1.64	2.83	10.82	51.68	1.87
Total Current Assets	296.56	368.33	538.47	442.45	586.97	94.82
Property, Plant & Equipment	51.89	61.02	53.71	48.58	52.44	17.68
Long-Term Investments	-	-	-	-	-	6
Goodwill	1.39	1.39	1.39	1.39	1.39	1.39
Other Intangible Assets	18.4	18.4	18.4	18.4	18.4	18.95
Other Long-Term Assets	2.5	2.31	3.13	2.4	2.59	3.22
Total Assets	370.74	451.45	615.11	513.21	661.78	142.06

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	12.11	11.64	18.03	15.58	10.7	4.78
Accrued Expenses	45.88	55.83	47.69	36.54	41.09	36.72
Current Portion of Leases	4.67	5.76	3.8	3.31	3.02	0.44
Other Current Liabilities	-	42.71	84.71	-	35.21	-
Total Current Liabilities	62.66	115.93	154.23	55.42	90.02	41.94
Long-Term Debt	259.48	238.9	-	-	-	-
Long-Term Leases	32.89	39.96	32.78	27.57	30.58	2.8
Other Long-Term Liabilities	3.49	4.58	4.66	2.25	2.41	2.64
Total Liabilities	358.52	399.38	191.67	85.24	123.01	47.37

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	2,139	1,934	1,657	887.53	615.74	34.69
Additional Paid-In Capital	220.37	193.98	112.37	39.8	13.87	-
Retained Earnings	-2,352	-2,085	-1,346	-499.29	-91.12	-
Comprehensive Income & Other	5.38	8.35	0.08	-0.07	0.28	-
Total Common Equity	12.22	52.07	423.44	427.98	538.77	34.69
Minority Interest	-	-	-	-	-	60
Shareholders' Equity	12.22	52.07	423.44	427.98	538.77	94.69
Total Liabilities & Equity	370.74	451.45	615.11	513.21	661.78	142.06

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	297.04	284.61	36.58	30.88	33.6	3.24
Net Cash (Debt)	-29.17	34.52	449.41	350.94	431.74	72.82
Net Cash Growth	-	-92.32%	28.06%	-18.71%	492.88%	-7.71%
Net Cash Per Share	-0.22	0.32	4.93	4.93	9.65	1.85
Filing Date Shares Outstanding	151.04	150.42	102.05	81.58	68.21	39.38
Total Common Shares Outstanding	151.02	132.78	101.22	81.12	68.19	39.38
Working Capital	233.9	252.4	384.25	387.02	496.95	52.89
Book Value Per Share	0.08	0.39	4.18	5.28	7.90	0.88
Tangible Book Value	-7.57	32.28	403.65	408.19	518.98	14.35
Tangible Book Value Per Share	-0.05	0.24	3.99	5.03	7.61	0.36
Buildings	-	14.08	14.08	11.73	12.3	12.3
Machinery	-	15.32	14.62	12.94	10.13	3.3
Leasehold Improvements	-	2.7	0.82	0.8	-	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 10, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error